R. Eliakim et al., Effect of chronic nicotine administration on trinitrobenzene sulphonic acid-induced colitis, EUR J GASTR, 10(12), 1998, pp. 1013-1019
Background Smoking, probably due to nicotine, has a bivalent effect on infl
ammatory bower disease, ameliorating disease activity in ulcerative colitis
and with a deleterious effect on Crohn's disease. The effect of nicotine p
atches in ulcerative colitis is controversial.
Aim To investigate the effect of chronic nicotine use in a rat model of col
itis.
Methods Colitis was induced in Sprague-Dawley rats by rectal administration
of 30 mg trinitrobenzene sulphonic acid (TNBS) in 50% ethanol. Nicotine wa
s dissolved in drinking water (2.5, 12.5, 25 and 250 mu g/ml), with rats dr
inking ad libitum. Nicotine administration started 10 days prior to damage
induction and had no effect on weight gain or daily food intake of rats. Ra
ts were sacrificed 1 and 5 days after TNBS administration, their colons res
ected, rinsed, weighed, damage assessed macroscopically (mm(2)) and microsc
opically and tissue processed for myeloperoxidase (MPO) and nitric oxide sy
nthase (NOS) activities, leukotriene B-4 (LTB4), prostaglandin E-2 (PGE(2))
generation and interleukin-1 (IL-1) serum levels.
Results Nicotine, by itself, caused no damage to the colon. Nicotine had a
dose-dependent bivalent effect on colitis, significantly reducing macroscop
ic damage from 983 +/- 10 mm(2) on TNBS alone to 429 +/- 118 mm(2) on TNBS
plus 12.5 mu g/ml of nicotine, and escalating to 1086 +/- 262 mm(2) on 250
mu g/ml of nicotine. Segmental weight declined significantly (from 2.4 +/-
0.2 to 1.65 +/- 0.20 g/10 cm), on 12.5 mu g/ml nicotine, as did MPO activit
y (from 3.2 +/- 0.4 to 0.7 +/- 0.1 units/g). All these parameters returned
to the levels of TNBS alone when the dose of nicotine was increased to 250
mu g/ml. Nicotine had no effect on NOS activity, PGE(2) generation and seru
m IL-1 levels, but increased LTB4 generation.
Conclusions Nicotine has a dose-dependent bivalent effect on TNBS-induced c
olitis which is not due to reduction in IL-1 serum levels or PGE(2) generat
ion, and is not NOS-mediated. Eur J Gastroenterol Hepatol 10:1013-1019 (C)
1998 Lippincott Williams & Wilkins.